Can the composition of the intestinal microbiota predict the development of urinary tract infections?

Future Microbiol. 2016 Oct:11:1395-1404. doi: 10.2217/fmb-2016-0088. Epub 2016 Oct 27.

Abstract

Aim: To evaluate whether intestinal microbiota predicts the development of new-onset urinary tract infections (UTIs) in postmenopausal women with prior recurrent UTIs (rUTIs).

Patients & methods: Fecal samples (n = 40) originated from women with rUTI who received 12 months' prophylaxis of either trimethoprim-sulfamethoxazole (TMP-SMX) or lactobacilli. Microbial composition was assessed by 16S rRNA pyrosequencing.

Results: At baseline, fecal microbiota of women with zero and more than or equal to four UTIs during follow-up showed no significant differences. Only TMP-SMX prophylaxis resulted in reduced microbial diversity. Microbial structure of two samples from the same woman showed limited relatedness.

Conclusion: In postmenopausal women with rUTI, the intestinal microbiota was not predictive for new-onset UTIs. Only TMP-SMX, and not lactobacilli, prophylaxis had effects on the microbial composition. Data in ENA:PRJEB13868.

Keywords: 16S rRNA pyrosequencing; intestinal microbiota; lactobacilli; postmenopausal women; prophylaxis; trimethoprim-sulfamethoxazole; urinary tract infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotic Prophylaxis
  • Biodiversity
  • DNA, Bacterial
  • Feces / microbiology
  • Female
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Microbiome / genetics
  • Humans
  • Lactobacillus
  • Microbiological Phenomena / drug effects*
  • Microbiological Phenomena / genetics
  • Middle Aged
  • Phylogeny
  • Postmenopause
  • Probiotics / therapeutic use
  • RNA, Ribosomal, 16S / genetics
  • Time Factors
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
  • Urinary Tract Infections / drug therapy*
  • Urinary Tract Infections / microbiology*
  • Urinary Tract Infections / prevention & control

Substances

  • DNA, Bacterial
  • RNA, Ribosomal, 16S
  • Trimethoprim, Sulfamethoxazole Drug Combination